Therapeutic VAB

THE THERAPEUTIC VALUE OF ULTRASOUND-GUIDED VACUUM BIOPSY OF BREAST FIBROADENOMAS.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON23277

Enrollment

196

Registered

2019-10-16

Start date

2020-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast fibroadenoma

Interventions

- Follow-up breast ultrasound - Breast-Q questionnaire - Cosmetic photo documentation

Eligibility

Inclusion criteria

Inclusion criteria: - women - > 18 years - histopathologically proven breast fibroadenoma - therapeutic vacuum biopsy in the period January 2015 till January 2019 - competent to sign informed consent

Exclusion criteria

Exclusion criteria: - Pregnant - Inconclusive histopathology - Microcalcifications - Suspected phyllodestumor - History of breast cancer locally treated with breast conserving surgery or ablation

Design outcomes

Primary

Measure	Time frame
Long-term effectiveness and patient satisfaction of therapeutic ultrasound-guided vacuum biopsy of BFA.	—

Secondary

Measure	Time frame
Cosmetic outcome.	—

Contacts

Public ContactGaelle Kramer

Dijklander Ziekenhuis

g.m.kramer@westfriesgasthuis.nl0639777015

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)